Iovance Biotherapeutics
IOVA
IOVA
217 hedge funds and large institutions have $1.1B invested in Iovance Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 83 increasing their positions, 71 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
217
Holders Change
-24
Holders Change %
-9.96%
% of All Funds
3.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
26
Increased
83
Reduced
71
Closed
47
Calls
$9.1M
Puts
$3.82M
Net Calls
+$5.28M
Net Calls Change
-$11.1M
Top Buyers
| 1 |
MFM
MHR Fund Management
New York
|
$76.7M |
| 2 |
State Street
Boston,
Massachusetts
|
$94M |
| 3 |
Morgan Stanley
New York
|
$31.8M |
| 4 |
Renaissance Technologies
New York
|
$20.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$14.7M |
